LEADER 03928nam  2200661Ia 450 
001 9910141169703321
005 20200520144314.0
010   $a1-283-40094-4
010   $a9786613400949
010   $a1-118-14049-4
010   $a1-118-14050-8
010   $a1-118-14047-8
035   $a(CKB)2670000000137426
035   $a(EBL)693203
035   $a(OCoLC)775064527
035   $a(SSID)ssj0000576188
035   $a(PQKBManifestationID)11399448
035   $a(PQKBTitleCode)TC0000576188
035   $a(PQKBWorkID)10553393
035   $a(PQKB)11684154
035   $a(MiAaPQ)EBC693203
035   $a(Au-PeEL)EBL693203
035   $a(CaPaEBR)ebr10523230
035   $a(CaONFJC)MIL340094
035   $a(PPN)243342209
035   $a(EXLCZ)992670000000137426
100   $a20110510d2011      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aTopical and transdermal drug delivery$b[electronic resource] $eprinciples and practice /$fedited by Heather A. E. Benson, Adam C. Watkinson
210   $aHoboken, N.J. $cWiley$dc2011
215   $a1 online resource (464 p.)
300   $aDescription based upon print version of record.
311   $a0-470-45029-0 
320   $aIncludes bibliographical references and index.
327   $aTransdermal and Topical Drug Delivery Principles and Practice; Contents; Preface; About the Editors; Contributors; Part One: Current Science, Skin Permeation, and Enhancement Approaches; Chapter 1: Skin Structure, Function, and Permeation; Chapter 2: Passive Skin Permeation Enhancement; Chapter 3: Electrical and Physical Methods of Skin Penetration Enhancement; Chapter 4: Clinical Applications of Transdermal Iontophoresis; Chapter 5: In Vitro Skin Permeation Methodology; Chapter 6: Skin Permeation Assessment: Tape Stripping; Chapter 7: Skin Permeation Assessment: Microdialysis
327   $aChapter 8: Skin Permeation: Spectroscopic MethodsChapter 9: Skin Permeation Assessment in Man: In Vitro-In Vivo Correlation; Chapter 10: Risk Assessment; Part Two: Topical and Transdermal Product Development; Chapter 11: An Overview of Product Development from Concept to Approval; Chapter 12: Regulatory Aspects of Drug Development for Dermal Products; Chapter 13: Toxicological and Pre-clinical Considerations for Novel Excipients and New Chemical Entities; Chapter 14: Topical Product Formulation Development; Chapter 15: Transdermal Product Formulation Development
327   $aChapter 16: Sensitivity and Irritation TestingChapter 17: New Product Development for Transdermal Drug Delivery: Understanding the Market Opportunity; Chapter 18: Transdermal and Topical Drug Delivery Today; Chapter 19: Current and Future Trends: Skin Diseases and Treatment; Index
330   $aPractical drug development approaches presented by leading experts Designed to support the development of new, effective therapeutics, Topical and Transdermal Drug Delivery: Principles and Practice explains the principles underlying the field and then demonstrates how these principles are put into practice in the design and development of new drug products. Drawing together and reviewing the latest research findings, the book focuses on practical, tested, and proven approaches that are backed by industry case studies and the authors' firsthand experience. Moreover, the book emp
606   $aDrug delivery systems
606   $aSkin absorption
606   $aTransdermal medication
615  0$aDrug delivery systems.
615  0$aSkin absorption.
615  0$aTransdermal medication.
676   $a615/.19
701   $aBenson$b Heather A. E$0944848
701   $aWatkinson$b Adam C$0944849
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910141169703321
996   $aTopical and transdermal drug delivery$92133143
997   $aUNINA